Testing effectiveness (Phase 2)Not Yet RecruitingNCT06971406
What this trial is testing
High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
Who this might be right for
Non Small Cell Lung CancerEGFR MutationLeptomeningeal Metastases+1 more
Qiming Wang 100